Premium
Homotypic Targeting Delivery of siRNA with Artificial Cancer Cells
Author(s) -
Zhang Lingmin,
Deng Sai,
Zhang Yanfen,
Peng Qingsheng,
Li Huan,
Wang Ping,
Fu Xiaomei,
Lei Xueping,
Qin Aiping,
Yu Xiyong
Publication year - 2020
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201900772
Subject(s) - cancer cell , internalization , gene delivery , cancer , small interfering rna , cell , microbiology and biotechnology , chemistry , cancer research , genetic enhancement , transfection , biology , gene , biochemistry , genetics
The camouflage with cell membrane bestows nanoparticles with cell‐like functions, such as specific recognition, long blood circulation, and immune escaping. For cancer therapy, the nanoparticles camouflaged with cancer cell membrane (CCM) from homologous cells show homotypic targeting delivery of small molecule compounds, photosensitizers, or enzymes to the tumors. However, effective gene therapy encounters difficulties by this approach due to the properties of nucleic acids. Herein, a cancer cell‐like gene delivery system is developed using an excellent polymer poly(β‐amino ester) (PBAE) to condense small interfering RNA (siRNA) (targeting to Plk1 gene) into nanoparticles (PBAE/siPlk1) as the core, which is further camouflaged with CCM. These novel biomimetic nanoparticles CCM/PBAE/siPlk1 (CCMPP) demonstrate highly specific targeting to homotypic cancer cells, effective downregulation of PLK1 level, and inducing apoptosis of cancer cells. Based on the homotypic binding adhesion molecules on the CCM, the cellular internalization and homotypic‐targeting accumulation to the tumors are clearly improved. CCMPP induces highly efficient apoptosis of cancer cells both in vitro and in vivo and results in significant tumor inhibition. The artificial cancer cells with homotypic properties can serve as a biomimetic delivery system for cancer‐targeted gene therapy.